Skip to main content
Top
Published in: The journal of nutrition, health & aging 5/2020

01-05-2020 | COVID-19 | Editorial

COVID-19 Spiraling of Frailty in Older Italian Patients

Authors: A. M. Abbatecola, R. Antonelli-Incalzi

Published in: The journal of nutrition, health & aging | Issue 5/2020

Login to get access

Excerpt

The world aging population is continuously rising and Italy is the second country following Japan with the largest concentration of persons living over the age of 65 years (1). At the moment, 22.4% of the Italian population is over the age of 65 years. Even though reaching advanced age in any country should be considered a significant and outstanding accomplishment, such triumph does not seem to come without sacrifice. Advanced aging is also accompanied by the increase in the risk of numerous comorbidities, such as arterial hypertension, heart disease, dementia, osteoporosis, cancer, Type 2 Diabetes, as well as other disease states that require continuous medical treatment. Most of these treatments require individual geriatric care modeling in order to maintain a “healthy” equilibrium necessary to avoid the irreversible spiral of the Frailty Syndrome. Frailty has been defined as a “syndrome characterized by a clinical state in which there is an increase in an individual’s vulnerability for developing an increased dependency and/or mortality when exposed to a stressor” (2). Frailty should be considered a constantly evolving syndrome and only reversible if appropriate intervention is quickly recognized and applied. Indeed, there is substantial literature underlining the importance of geriatric medicine toward frailty prevention and clinical criteria to rapidly identify those with frailty or pre-frailty (35). If any negative health conditions break the equilibrium, the irreversible downward spiraling of frailty will begin. Over the last few months, there has been a worldwide rise infection of Coronavirus disease (COVID-19). As of March 27th, the country of Italy has over 79,900 persons infected with COVID-19 and 7590 deaths associated with COVID-19. Therefore, due to the rapid spread of the coronavirus in Italy, there seems to be a deadly trend toward mortality with COVID-19 in older patients with specific comorbidities, thus identifying a new “COVID Spiraling Frailty Syndrome”. This brief commentary will provide recent findings related to age-related comorbidities commonly found in advanced age and their percentages in older Italians that have recently died with a COVID-19. We will also consider potential aspects of different drugs for such comorbidities and COVID-19. This commentary specifically focuses on the Italian population of older patients in the last month of disease spread. …
Literature
1.
go back to reference International Institute for Applied System Analysis (IIASA), Aging Demographic Data Sheet 2018 (Laxenburg, Austria: IIASA, 2018) International Institute for Applied System Analysis (IIASA), Aging Demographic Data Sheet 2018 (Laxenburg, Austria: IIASA, 2018)
2.
go back to reference Morley JE, Vellas B, van Kan GA, et al. Frailty consensus: a call to action. J Am Med Dir Assoc. 2013;14(6): 392–7.CrossRef Morley JE, Vellas B, van Kan GA, et al. Frailty consensus: a call to action. J Am Med Dir Assoc. 2013;14(6): 392–7.CrossRef
3.
go back to reference Dent E, Morley JE, Cruz-Jentoft AJ, et al. Physical Frailty: ICFSR International Clinical Practice Guidelines for Identification and Management. J Nutr Health Aging. 2019;23(9): 771–787.CrossRef Dent E, Morley JE, Cruz-Jentoft AJ, et al. Physical Frailty: ICFSR International Clinical Practice Guidelines for Identification and Management. J Nutr Health Aging. 2019;23(9): 771–787.CrossRef
4.
go back to reference Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):M146–56.CrossRef Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):M146–56.CrossRef
5.
go back to reference Dent E, Morley JE, Cruz-Jentoft AJ, et al. International Clinical Practice Guidelines for Sarcopenia (ICFSR): Screening, Diagnosis and Management. J Nutr Health Aging. 2018; 22(10): 1148–1161.CrossRef Dent E, Morley JE, Cruz-Jentoft AJ, et al. International Clinical Practice Guidelines for Sarcopenia (ICFSR): Screening, Diagnosis and Management. J Nutr Health Aging. 2018; 22(10): 1148–1161.CrossRef
7.
go back to reference Choi KW, Chau TN, Tsang O, et al. Princess Margaret Hospital SARS Study Group. Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong. Ann Intern Med. 2003;139(9): 715–23.CrossRef Choi KW, Chau TN, Tsang O, et al. Princess Margaret Hospital SARS Study Group. Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong. Ann Intern Med. 2003;139(9): 715–23.CrossRef
8.
go back to reference Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020 Feb 24. pii: S2213-2600(20)30079-5. Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020 Feb 24. pii: S2213-2600(20)30079-5.
9.
go back to reference Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 11. pii: S0140-6736(20)30566-3. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 11. pii: S0140-6736(20)30566-3.
10.
go back to reference Zhang L, Ma L, Sun F, Tang Zhe, Chan P. A Multicenter Study of Multimorbidity in Older Adult Inpatients in China. J Nutr Health Aging. 2020;24(3): 269–276.CrossRef Zhang L, Ma L, Sun F, Tang Zhe, Chan P. A Multicenter Study of Multimorbidity in Older Adult Inpatients in China. J Nutr Health Aging. 2020;24(3): 269–276.CrossRef
11.
go back to reference Lu J, Lu Y, Wang X, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from 1•7 million adults in a population-based screening study (China PEACE Million Persons Project). Lancet. 2017;390(10112): 2549–2558.CrossRef Lu J, Lu Y, Wang X, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from 1•7 million adults in a population-based screening study (China PEACE Million Persons Project). Lancet. 2017;390(10112): 2549–2558.CrossRef
12.
go back to reference Bullock GR, Steyaert I, Bilbe G, et al. Distribution of type-1 and type-2 angiotensin receptors in the normal human lung and in lungs from patients with chronic obstructive pulmonary disease. Histochem Cell Biol. 2001;115(2): 117–24.CrossRef Bullock GR, Steyaert I, Bilbe G, et al. Distribution of type-1 and type-2 angiotensin receptors in the normal human lung and in lungs from patients with chronic obstructive pulmonary disease. Histochem Cell Biol. 2001;115(2): 117–24.CrossRef
13.
go back to reference Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus. J Virol. 2020 Mar 17;94(7). Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus. J Virol. 2020 Mar 17;94(7).
14.
go back to reference Gallagher PE, Ferrario CM, Tallant EA. Regulation of ACE2 in cardiac myocytes and fibroblasts. Am J Physiol Heart Circ Physiol. 2008;295(6):H2373–9.CrossRef Gallagher PE, Ferrario CM, Tallant EA. Regulation of ACE2 in cardiac myocytes and fibroblasts. Am J Physiol Heart Circ Physiol. 2008;295(6):H2373–9.CrossRef
15.
go back to reference Fedson DS. Treating the host response to emerging virus diseases: lessons learned from sepsis, pneumonia, influenza and Ebola. Ann Transl Med 2016;4:421.CrossRef Fedson DS. Treating the host response to emerging virus diseases: lessons learned from sepsis, pneumonia, influenza and Ebola. Ann Transl Med 2016;4:421.CrossRef
16.
go back to reference Santos SH, Braga JF, Mario EG, et al. Improved lipid and glucose metabolism in transgenic rats with increased circulating angiotensin-(1–7). Arterioscler Thromb Vasc Biol. 2010;30(5): 953–61.CrossRef Santos SH, Braga JF, Mario EG, et al. Improved lipid and glucose metabolism in transgenic rats with increased circulating angiotensin-(1–7). Arterioscler Thromb Vasc Biol. 2010;30(5): 953–61.CrossRef
17.
go back to reference Chhabra KH, Chodavarapu H, Lazartigues E. Angiotensin converting enzyme 2: a new important player in the regulation of glycemia. IUBMB Life. 2013;65(9): 731–8.CrossRef Chhabra KH, Chodavarapu H, Lazartigues E. Angiotensin converting enzyme 2: a new important player in the regulation of glycemia. IUBMB Life. 2013;65(9): 731–8.CrossRef
Metadata
Title
COVID-19 Spiraling of Frailty in Older Italian Patients
Authors
A. M. Abbatecola
R. Antonelli-Incalzi
Publication date
01-05-2020
Publisher
Springer Paris
Keyword
COVID-19
Published in
The journal of nutrition, health & aging / Issue 5/2020
Print ISSN: 1279-7707
Electronic ISSN: 1760-4788
DOI
https://doi.org/10.1007/s12603-020-1357-9

Other articles of this Issue 5/2020

The journal of nutrition, health & aging 5/2020 Go to the issue